A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Expects first quarter 2020 revenue of $8.6 million to $8.7 millionWINTER SPRINGS, Fla., April 07, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is withdrawing its first...
WINTER SPRINGS, Fla., March 12, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020. Mr. Neuhardt will report to Leslie McDonnell, President and Chief Executive...
WINTER SPRINGS, Fla., March 06, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that Leslie McDonnell, President and Chief Executive Officer, will present at the 32nd Annual Roth Conference in Laguna Niguel, CA. Ms. McDonnell is scheduled to present on...
WINTER SPRINGS, Fla., Feb. 26, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance, effective June 30, 2020 after leading the Company's regulatory efforts since 2004....
Reports fourth quarter 2019 revenue of $10.9 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.30Renewed CE Mark for patient vital signs monitor and shipped associated backlog during the fourth quarter 2019Announces 2020 full year and first quarter...
WINTER SPRINGS, Fla., Jan. 22, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 fourth quarter financial results before the market opens on Thursday, February 6th. IRADIMED management will host a conference call the...
WINTER SPRINGS, Fla., Jan. 07, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company's commercial efforts since 2012....
Immediately resumes shipments of patient vital signs monitoring systems into all markets requiring CE Mark WINTER SPRINGS, Fla., Dec. 12, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical...
Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Updates full-year financial guidance WINTER SPRINGS, Fla., Oct. 30, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative...
WINTER SPRINGS, Fla., Oct. 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market opens on Wednesday, October 30th. IRADIMED management will host a conference call the...